Medtronic Continuous Glucose Monitoring System
Avoid Highs and Lows with a Medtronic CGM!
Medtronic Guardian™ Connect CGM
Medtronic Guardian Connect CGM is the world’s first Smart Continuous Glucose Monitoring (CGM)* system for people on insulin injections. With breakthrough tools to outsmart the highs and lows of diabetes, the Guardian Connect CGM allows you to focus on your life — not on your levels. Using smart technology to predict where your glucose levels are headed, the system will alert you from 10 to 60 minutes before a high or low.
Customizable glucose alerts built for you
Real-time glucose trends through the app
Updates glucose data every 5 minutes
Can be used for Type 1 or Type 2 diabetes
———- Discover More ———-
Introducing the Guardian Connect
Guardian Connect: Have More Good Days
What is a CGM?
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes.
Once you have enrolled, your dedicated Diabetes Care Advisor (DCA) will verify your insurance benefits and obtain a prescription from your physician. Within two business days, your DCA will contact you to explain your options and go over everything you need. We handle all necessary paperwork between your insurance and your healthcare team, keeping you updated every step of the way.
The MiniMed™ 600-series pumps use the Guardian™ Link 3 transmitter, which uses a different wireless technology to communicate with the pump. The transmitter shell for the Guardian™ Connect system also has a “GC” etched on the surface opposed to the pump system transmitter shell, which just has a “G.”
*The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus.
*The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
*Alerts must be set to receive predictive alerts.